AbbVie Inc. (ABBV)
NYSE
Closed
Aug 21, 2026
Day's Range
260.1052 wk Range
190.75Overview - ABBV - AbbVie Inc.
Key Statistics
Valuation
Enterprise Value
527.04B
P/E (Trailing)
‪75.05‬
P/E (Forward)
‪16.31‬
PEG Ratio
‪0.26‬
Price / Sales (TTM)
‪7.27‬
Price / Book
‪-79.60‬
EV / EBITDA
‪17.13‬
Profitability
Gross Margin
‪74.74%‬
Profit Margin
‪9.80%‬
Operating Margin
‪40.03%‬
Return on Assets
‪10.51%‬
Return on Equity
‪-129.67%‬
Ownership
Shares Outstanding
1.76B
Float
1.76B
Short % of Shares Outstanding
‪1.41%‬
Held by Insiders
‪0.11%‬
Held by Institutions
‪77.43%‬
Price stats
Beta
‪0.28‬
50-Day Avg
‪247.19‬
200-Day Avg
‪226.30‬
Dividends
Payout Ratio
‪190.39%‬
Frequency
Quarterly
Analyst Consensus
31 analysts
Average price target
‪$ 276.41‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ABBV - AbbVie Inc.
Peers - ABBV - AbbVie Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- ABBVNYSEAbbVie Inc.468.21BMarket Cap+21.67%52-week change75.06P/E (Trailing)‪9.80%‬Profit Margin
- LLYNYSEEli Lilly and Company1.11TMarket Cap+44.61%52-week change42.21P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson651.25BMarket Cap+33.98%52-week change31.50P/E (Trailing)‪21.48%‬Profit Margin
- MRKNYSEMerck & Co., Inc.376.36BMarket Cap+44.08%52-week change122.12P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR301.94BMarket Cap+21.29%52-week change24.00P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander S.A. Sponsored ADR212.65BMarket Cap+34.20%52-week change14.27P/E (Trailing)‪33.46%‬Profit Margin
- NVONYSENovo Nordisk A/S206.68BMarket Cap-20.54%52-week change11.59P/E (Trailing)‪35.34%‬Profit Margin
Profile Summary - ABBV - AbbVie Inc.
About
AbbVie Inc. is a research-based biopharmaceutical company that discovers, develops, manufactures, and commercializes innovative medicines and therapies worldwide. The company maintains a strong focus on immunology, offering treatments like Humira, Skyrizi, and Rinvoq for autoimmune and inflammatory conditions in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
